Food Allergy Research & Education

FARE Celebrates New Teacher Training Law in New York

Retrieved on: 
Tuesday, September 19, 2023
Linda, Commissioner, State, Senate, FARE, Food allergy, Parent, Anxiety, Food, Fear, Doctor of Philosophy, Student, Anaphylaxis, Adrenaline, RN, Food Allergy Research & Education, Legislation, Tutoring, Health

MCLEAN, Va., Sept. 18, 2023 /PRNewswire/ -- FARE (Food Allergy Research & Education) thanks food allergy advocates, and Assemblymember Linda B. Rosenthal (D/WF-Manhattan), State Senator Cordell Cleare (D-30), Governor Kathy Hochul, and their staffs for passing Senate Bill S209A, an epinephrine auto-injector teacher training bill, signed into law on Friday evening. The tireless efforts of our advocates were instrumental in getting this bill, a version of which was originally introduced more than 12 years ago, passed.

Key Points: 
  • This new teacher training law ensures that students are better protected and safer in the place where they spend most of their day – the classroom.
  • FARE Advocates Jill Mindlin and Stacey Saiontz, parents of school age children, led the decade-plus long effort to pass this legislation.
  • This law will make a huge difference in the lives of all NY families with school aged children living with food allergies," says Mindlin.
  • Over the 12-year lobbying effort, food allergy advocates were joined by teachers, who wanted this essential information, to help build momentum for this law.

2023 Global Allergy Treatment Market Forecasted to Grow with Increasing Prevalence of Allergies Worldwide - ResearchAndMarkets.com

Retrieved on: 
Monday, August 14, 2023
General Health, Pharmaceutical, Health, Allergy, Asthma, Headache, Prevalence, Atmosphere, Biotechnology, Food, Research, Immunotherapy, Peanut allergy, Sleep, Growth, Food Allergy Research & Education, Air pollution, Pharmaceutical industry

The "Global Allergy Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Allergy Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global allergy treatment market is anticipated to witness a growth of steady CAGR in the forecast period, 2023-2027.
  • Additionally, the growing use of over-the-counter medications and the increasing popularity of self-medication is further expected to create lucrative opportunities for the growth of global allergy treatment market.
  • This, in turn, is expected to create lucrative opportunities for the growth of global allergy treatment market.

New Industry Report Highlights Gaps and Areas for Innovation in Addiction Treatment

Retrieved on: 
Tuesday, August 8, 2023
Housing, Prevalence, Education, Addiction, Policy, Drug overdose, Fatality, Statistics, Organization, Death, Food Allergy Research & Education, SUD, Ageing, National Association, Transport, Substance use disorder, Fentanyl, Pharmaceutical industry

DELRAY BEACH, Fla., Aug. 8, 2023 /PRNewswire-PRWeb/ -- Sunwave Health, a leading provider of technology-driven treatment solutions for behavioral health providers, today released a comprehensive industry report highlighting the critical need for innovative approaches to addiction treatment in the United States. Based on in-depth interviews with industry leaders and front-line professionals, the report reveals alarming statistics and emphasizes the urgency for new solutions in addressing the ongoing crisis.

Key Points: 
  • With an impressive combined decades of experience, these contributors provide valuable perspectives organized into an original framework and report known as the Addiction Treatment Innovator's Playbook .
  • This framework emphasizes the importance of collaboration among stakeholders and the need for technological advancements to enhance addiction treatment.
  • The report identifies a significant disparity in funding for addiction treatment compared to other complex diseases.
  • Notably, venture capital investment in addiction treatment remains disproportionately low, with cancer treatment receiving nearly 270 times more funding despite similar prevalence rates.

NATIONAL LANDMARKS AND NFL STADIUMS LIGHT UP TEAL TO CELEBRATE FARE'S FOOD ALLERGY AWARENESS WEEK

Retrieved on: 
Friday, May 19, 2023
Sport, FARE, Location, Food allergy, Gillette Stadium, Food, Research, Empire, Hard Rock Stadium, Rock & Roll Hall of Fame Covers EP, Rock, Food Allergy Research & Education, Sports Illustrated, Cochineal, Mark Canha, Teal

MCLEAN, Va., May 19, 2023 /PRNewswire/ -- As part of FARE's (Food Allergy Research & Education's) ongoing work to raise awareness of food allergies, the organization sets aside one week in May as Food Allergy Awareness Week to bring the complexities of food allergy to "light." This year's celebration highlighted the organization's educational, research and advocacy efforts by "lighting up" landmarks and stadiums across the country in Teal – the color of food allergy – to remind people of the importance of the food allergy cause. Recognizable locations included the Empire State Building, the Rock & Roll Hall of Fame, Niagara Falls, Gillette Stadium, and Hard Rock Stadium.

Key Points: 
  • Shine the Light on Supporting Those Living with Food Allergies
    MCLEAN, Va., May 19, 2023 /PRNewswire/ -- As part of FARE's (Food Allergy Research & Education's) ongoing work to raise awareness of food allergies, the organization sets aside one week in May as Food Allergy Awareness Week to bring the complexities of food allergy to "light."
  • This year's celebration highlighted the organization's educational, research and advocacy efforts by "lighting up" landmarks and stadiums across the country in Teal – the color of food allergy – to remind people of the importance of the food allergy cause.
  • FARE's Food Allergy Awareness Week is all about raising awareness of the severity of food allergies, and there couldn't be a better visual for our message than turning national landmarks teal.
  • To learn more about food allergies or how to become a food allergy ally, visit FARE .

FARE Honors Impactful Food Allergy Women during Women's History Month

Retrieved on: 
Monday, March 20, 2023
Women's History Month, Bachelor, University, Nut, Freedom, FARE, Education, Food allergy, Nursing, Food, Tufts University, State university system, Business, Woman, Washington College of Law, Epinephrine autoinjector, Research, Attention, Doctor of Philosophy, Hartman, Student, Work, Patient, Restaurant, Adrenaline, Love, JD, Food Allergy Research & Education, Legislation, Pharmaceutical industry, Cochineal, Rutgers University

MCLEAN, Va., March 20, 2023 /PRNewswire/ -- Food Allergy Research & Education (FARE) is proud to honor and highlight three women who have made and are continuing to make a huge impact in the food allergy space.

Key Points: 
  • MCLEAN, Va., March 20, 2023 /PRNewswire/ -- Food Allergy Research & Education (FARE) is proud to honor and highlight three women who have made and are continuing to make a huge impact in the food allergy space.
  • During Women's History Month, FARE recognizes the dedication and commitment of these individuals in research, advocacy, education, awareness, philanthropy and leadership, whose work is raising awareness of food allergy as a top tier disease while solidifying FARE's role as THE trusted food allergy resource.
  • FARE's impactful food allergy women include:
    Kim Hartman, whose son faced deadly allergies to all nuts, is a compassionate philanthropist, dedicated food allergy mom, serial entrepreneur/vc, and impactful advocate for the cause and treatments of food allergy.
  • Saiontz continues as an active supporter and advocate of all things food allergy and is an invaluable member of the FARE and food allergy communities.

DBV Technologies to Participate in Upcoming AAAAI 2023 Congress

Retrieved on: 
Tuesday, February 21, 2023
CST, San Antonio Marriott Rivercenter, Pediatrics, DBV Technologies, Food Allergy Research & Education, Food, FIT, Girl on the Third Floor, Northwestern University, Food allergy, American Academy of Allergy, Asthma, and Immunology, Icahn School of Medicine at Mount Sinai, Safety, Children's Hospital Colorado, Fellows, AAAAI, Patient, Atopic dermatitis, DBV, Skin, Peanut allergy, Feinberg School of Medicine, University, Research, Medicine, Associate, American Academy, Asthma, Mount Sinai, University of Arkansas for Medical Sciences, MD, Vaccine, Medical device, Euronext

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced upcoming participation at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Scientific meeting, taking place February 24-27 in San Antonio, TX.

Key Points: 
  • DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced upcoming participation at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Scientific meeting, taking place February 24-27 in San Antonio, TX.
  • DBV will also host a booth in the AAAAI exhibit hall (#1826).
  • This year’s meeting will also feature a non-CME Product Theater on the Immunological Role of the Skin in Food Allergy.
  • DBV is also proud to sponsor the AAAAI Fellows-in-Training (FIT) Program reception.

FARE PARTNERS WITH VIONIC TO LAUNCH ITS FUTURE STARTS NOW CAMPAIGN

Retrieved on: 
Tuesday, December 20, 2022
Partner, Education, RN, Comfort, NYSE, Today (American TV program), Health, Famous Footwear, CAL, Disease, Partnership, Food, Marketing, Life, Women's health, FARE, Human, Food allergy, Food Allergy Research & Education, Legislation, O, The Oprah Magazine, Doctor of Philosophy, E-commerce, Research, Men's Health, Woman, Tourism, Medicine, Taxicab, Fashion, Caleres, Naturalizer, Vionic, InStyle

MCLEAN, Va., Dec. 20, 2022 /PRNewswire/ -- Food Allergy Research & Education's (FARE) new partner Vionic is dedicated to helping fund research and education for individuals living with life threatening food allergies. FARE raised $220,000 on Giving Tuesday and kicked off its Future Starts Now year-end campaign with the goal of raising $1 million before the end of the year.

Key Points: 
  • FARE raised $220,000 on Giving Tuesday and kicked off its Future Starts Now year-end campaign with the goal of raising $1 million before the end of the year.
  • Vionic customers can select FARE as their charity of choice and donate up to $50 when they purchase Vionic shoes at vionicshoes.com.
  • Together, FARE and Vionic can make an impact on the food allergy community by driving awareness to the cause.
  • About Vionic: Vionic designs its Three-Zone Comfort technology into every shoe it makes, resulting in unparalleled stability, ultimate arch support, and cushioning.

NFL's Justin Fields and NBA's Austin Reaves Join Leading Allergen-Friendly Brand, OWYN, in $100,000 Matching Donation to Support Food Allergy Non-Profit FARE: Future Starts Now Campaign

Retrieved on: 
Tuesday, December 13, 2022
Chicago Bears, Anaphylaxis, Food, Doctor of Philosophy, Food allergy, Shellfish, RN, Food Allergy Research & Education, Kroger, HBC, Research, Allergen, Disease, Legislation, Allergy, Future, Education, Los Angeles Lakers, FARE, Emergency, Pharmaceutical industry, Taxicab, Cochineal, Grocery store

NEW YORK, Dec. 13, 2022 /PRNewswire/ -- To support the lifesaving food allergy research and education by FARE (Food Allergy Research & Education), the nation's leading non-profit engaged in food allergy research, education and advocacy, OWYN (stands for Only What You Need), the No. 1 vegan protein shake brand, announces a matching donation of $100,000 in collaboration with brand partners Chicago Bears quarterback, Justin Fields and L.A. Lakers' Austin Reaves to FARE's Future Starts Now campaign.

Key Points: 
  • 1 vegan protein shake brand, announces a matching donation of $100,000 in collaboration with brand partners Chicago Bears quarterback, Justin Fields and L.A. Lakers' Austin Reaves to FARE's Future Starts Now campaign .
  • These funds impact FARE's critical initiatives that transform the future of food allergy.
  • I want to show my full support and understand how crucial FARE's mission is for the entire food allergy community.
  • FARE (Food Allergy Research & Education) is the nation's leading non-profit engaged in food allergy advocacy as well as the largest private funder of food allergy research.

FARE and Sifter Announce Grocery Shopping Technology for the Food Allergy Community

Retrieved on: 
Thursday, November 10, 2022
GLOBE, FARE, Doctor of Philosophy, Partnership, Research, Technology, Reading, RN, Legislation, Food allergy, Food, Food Allergy Research & Education, Time, Allergy, Disease, Nutrition, Algorithm, Tamás Sifter, Retail, Peapod, Sieve

MCLEAN, Va., Nov. 10, 2022 (GLOBE NEWSWIRE) -- FARE (Food Allergy Research & Education), the nation's leading non-profit organization engaged in food allergy advocacy and the largest private funder of food allergy research, and Sifter SP, Inc., a leader in food and nutrition digital technology, announce a partnership that will help make grocery shopping easier and less time-consuming.

Key Points: 
  • MCLEAN, Va., Nov. 10, 2022 (GLOBE NEWSWIRE) -- FARE (Food Allergy Research & Education), the nation's leading non-profit organization engaged in food allergy advocacy and the largest private funder of food allergy research, and Sifter SP, Inc., a leader in food and nutrition digital technology, announce a partnership that will help make grocery shopping easier and less time-consuming.
  • Built by a team of Sifter nutrition experts and software developers and powered by algorithms that support dietary standards of practice, the Sifter technology is designed to help the food allergy community make better food decisions and also take the fear out of grocery shopping.
  • "Grocery shopping for members of the food allergy community has always been challenging due to the scrutiny necessary in reading ingredient labels.
  • About FARE: FARE (Food Allergy Research & Education) is the nation's leading non-profit engaged in food allergy advocacy as well as the largest private funder of food allergy research.

RESEARCHERS AT BOULDER CARE PUBLISH A NOVEL CLINICAL METHOD TO COMBAT OVERDOSE CRISIS

Retrieved on: 
Thursday, September 29, 2022
People, HIV/AIDS, Department of Medicine – University of Pamplona, Fentanyl, Traction, QuickStart, Journal, Department, Risk, Buprenorphine, OUD, University of Massachusetts, Drug overdose, Addiction medicine, Community health, Face, World war, Pharmacy, Journal of Addiction Medicine, Patient, History, Burns, Fatality, Public health, Heroin, Goal, DNP, MAT, United States drug overdose death rates and totals over time, Wilfrid Sellars, Fear, Food Allergy Research & Education, Associate, Research, Drug, Mortality, Naloxone, University, Medical director, University of Pittsburgh School of Medicine, Pharmaceutical industry, Hospital, Residential care, Medicine

PORTLAND, Ore., Sept. 29, 2022 /PRNewswire/ -- As the U.S. is suffering the worst overdose crisis in its history, illicitly manufactured fentanyl – a synthetic opioid 50 times more potent than heroin – now largely dominates the drug supply.1 The "Fentanyl Era" has created formidable new challenges, both for patients seeking addiction treatment and for care providers helping them on the frontlines.

Key Points: 
  • New findings from researchers at addiction medicine provider Boulder Care offer an important solution, in the form of a compelling clinical innovation called the "QuickStart" method.
  • He did so by self-administering intranasal naloxone, commonly known as Narcan, the overdose reversal medication available in most pharmacies.
  • The patient remains in care with BUP-NX and says, "I think [this method] will save a lot of lives."
  • For more information about the study or clinical method described, visit: www.boulder.care/quickstart
    The authors are currently completing a case series of the new method for expedited publication.